NUCLEOSIDE PHOSPHATE ANALOGUES WITH BORONATED PHOSPHATES
含硼磷酸盐的核苷磷酸类似物
基本信息
- 批准号:3489416
- 负责人:
- 金额:$ 4.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-08-01 至 1992-03-31
- 项目状态:已结题
- 来源:
- 关键词:antineoplastics antiviral agents boron cell membrane chemical stability cytotoxicity drug design /synthesis /production enzyme induction /repression enzyme mechanism membrane permeability neutron radiation nuclease nucleic acid chemical synthesis nucleotide analog nucleotide metabolism phosphates phosphorylation radionuclide therapy stereochemistry synthetic nucleotide
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract) Use of nucleoside
phosphates as antitumor and antiviral agents has been limited by their
inability to penetrate cell membranes as well as their high susceptibility
to enzymes such as phosphatases, nucleotidases, etc. Modification of the
phosphate group (by replacing one of the nonbridging oxygens with a borane
group) may provide both the membrane permeability to these compounds and
the stability (towards phosphate-removing enzymes).
The long term objective of this project is to synthesize nucleoside mono-,
di-and triphosphates in which one of the oxygens of alpha, beta or gamma
phosphorus has been replaced with an isoelectric borane group. These
compounds may be prepared by phosphorylation of nucleosides, nucleoside
monophosphates and nucleoside diphosphates using a boronated
phosphorylating agent. In their studies with related oligonucleotide
boranophosphates, the P-BH3 moiety has been found to be remarkably stable
and the oligonucleotide boranophosphates have high nuclease resistance.
The nucleoside boranophosphates may be useful in a number of ways
including: l) as tools for studying mechanism of action of enzymes, 2) as
antiviral and antitumor agents, and 3) as carriers of boron neutron capture
therapy.
描述:(改编自申请人的摘要)核苷的使用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNARD F SPIELVOGEL其他文献
BERNARD F SPIELVOGEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNARD F SPIELVOGEL', 18)}}的其他基金
NEW (B22H22)2 FOR NEUTRON CAPTURE AND DIAGNOSTICS
用于中子捕获和诊断的新型 (B22H22)2
- 批准号:
2776444 - 财政年份:1999
- 资助金额:
$ 4.99万 - 项目类别:
REPRODUCTIVE TOXICOLOGY OF BORON ANALOGS OF BIOMOLECULES
生物分子硼类似物的生殖毒理学
- 批准号:
2203890 - 财政年份:1994
- 资助金额:
$ 4.99万 - 项目类别:
BORONATED ASPARAGINE AND GLUTAMINE ANALOGS FOR BNCT
BNCT 的硼化天冬酰胺和谷氨酰胺类似物
- 批准号:
2108414 - 财政年份:1994
- 资助金额:
$ 4.99万 - 项目类别:
AMINE-BORANES AS NEW TOPOISOMERASE II INHIBITORS
胺硼烷作为新的拓扑异构酶 II 抑制剂
- 批准号:
3493267 - 财政年份:1993
- 资助金额:
$ 4.99万 - 项目类别:
NUCLEOSIDE PHOSPHATE ANALOGS WITH BORONATED PHOSPHATES
含硼磷酸盐的核苷磷酸类似物
- 批准号:
2065963 - 财政年份:1991
- 资助金额:
$ 4.99万 - 项目类别:
OLIGONUCLEOTIDES WITH BORONATED PHOSPHORUS BACKBONES
具有硼化磷骨架的寡核苷酸
- 批准号:
3506903 - 财政年份:1991
- 资助金额:
$ 4.99万 - 项目类别:
NUCLEOSIDE PHOSPHATE ANALOGS WITH BORONATED PHOSPHATES
含硼磷酸盐的核苷磷酸类似物
- 批准号:
2065962 - 财政年份:1991
- 资助金额:
$ 4.99万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 4.99万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 4.99万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 4.99万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 4.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 4.99万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 4.99万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 4.99万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 4.99万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 4.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 4.99万 - 项目类别:














{{item.name}}会员




